Here is your NEWS-Line for Laboratory Professionals eNewsletter. For the latest news, jobs, education and blogs, bookmark our news page and job board or to take us everywhere with you, save this link to your phone. Also, enjoy the latest issue of NEWS-Line magazine, always free.
NEWS:
Molecular Analysis Identifies Key Differences in Lungs of Cystic Fibrosis Patients
A team of researchers from UCLA, Cedars-Sinai and the Cystic Fibrosis Foundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.
The catalog, described in the journal Nature Medicine, reveals new subtypes of cells and illustrates how the disease changes the cellular makeup of the airways. The findings could help scientists in their search for specific cell types that represent prime targets for genetic and cell therapies for cystic fibrosis.
"This new research has provided us with valuable insights into the cellular makeup of both healthy and diseased airways," said Dr. Brigitte Gomperts, a co-senior author of the study and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. "If you can understand how things work in a state of health, it becomes easier to see w
Read Full Article
Battling Public Health Misinformation Online
Social media and web-based news channels became a communication superhighway for correct and incorrect public health information during the COVID-19 pandemic. The study of this vast amount of information, known as infodemiology, is critical to building public health interventions to combat misinformation and help individuals, groups, and communities navigate and distill crucial public health messages.
In a novel effort to combat COVID-19 misinformation, a group of women researchers, including nurse scientists from the University of Pennsylvania School of Nursing (Penn Nursing), launched the Dear Pandemic social media campaign in March 2020. It delivers curated, comprehensive, and timely information about the COVID-19 pandemic in a question-and-answer format. Complex topics such as COVID-19 aerosol transmission, risk reduction strategies to avoid infection, and excess mortality are expl
Read Full Article
Ticking Upward: MU Researcher Studies Rise of Tick-Borne Diseases in Midwest
When Ram Raghavan heard from a former colleague at the Centers for Disease Control and Prevention that a 7-year-old girl had died from Rocky Mountain spotted fever as the result of a tick bite, he thought of his own daughter, also 7 years old at the time, and the potentially fatal danger posed to vulnerable populations by tick-borne diseases.
Now a professor at the University of Missouri College of Veterinary Medicine and School of Health Professions, Raghavan is an epidemiologist studying how ticks, mosquitos and other arthropods spread disease that impact people, pets and livestock over time in various geographical regions.
In a recent study, the most comprehensive of its kind in the Midwest region of the United States, Raghavan and former graduate student Ali Hroobi collected and identified various species of ticks on the outskirts of Pittsburg, Kansas, twice a month for a 3-year pe
Read Full Article
Cancer Treatments May Accelerate Cellular Aging
New research indicates that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue. The findings are published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Gene activity is often adjusted during life through epigenetic changes, or physical modifications to DNA that do not involve altering the underlying DNA sequence. Some individuals may experience epigenetic age acceleration (EAA) that puts them at a higher risk of age-related conditions than other individuals of the same chronological age. Investigators recently examined EAA changes during and following cancer treatment, and they looked for a potential link between these changes and fatigue in patients with head and neck cancer (HNC).
In the study of 133 patients with HNC, half of the patients experi
